Spots Global Cancer Trial Database for hepatitis b
Every month we try and update this database with for hepatitis b cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening | NCT04659005 | Hepatitis B Hepatocellular ... | Nurse-led decis... Usual care | 18 Years - 65 Years | Chinese University of Hong Kong | |
| Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan | NCT02402699 | Advanced Melano... Hepatitis B Hepatitis C | 18 Years - | Bristol-Myers Squibb | ||
| Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer | NCT05181826 | Cancer Liver Cirrhosis Chronic Hepatit... Hepatitis B Hepatitis C Diabetes COPD | Multi-analyte B... | 18 Years - | Helio Genomics | |
| Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer | NCT05181826 | Cancer Liver Cirrhosis Chronic Hepatit... Hepatitis B Hepatitis C Diabetes COPD | Multi-analyte B... | 18 Years - | Helio Genomics | |
| Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity | NCT02148562 | Hepatitis B Hepatitis B, Ch... End Stage Liver... Carcinoma, Hepa... | - | Universitaire Ziekenhuizen KU Leuven | ||
| Application of HBV Rapid Tests as a Tool for Wide-Use Screening | NCT01767597 | Hepatitis B Liver Cirrhosis Carcinoma, Hepa... | ELISA testing Rapid testing | 18 Years - | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | |
| Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI | NCT00154531 | Hepatocellular ... Hepatitis B Hepatitis C | 0 Years - | National Taiwan University Hospital | ||
| Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B | NCT00926757 | Non Hodgkin's L... Hepatitis B | Entecavir proph... Therapeutic ent... | 16 Years - | Taipei Veterans General Hospital, Taiwan | |
| Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population | NCT06379334 | Hepatocellular ... Hepatitis B | Urine test | 18 Years - 100 Years | Peking Union Medical College Hospital | |
| Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC | NCT00834158 | Hepatocellular ... | TACE PVE | 20 Years - 65 Years | Eastern Hepatobiliary Surgery Hospital | |
| Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity | NCT02148562 | Hepatitis B Hepatitis B, Ch... End Stage Liver... Carcinoma, Hepa... | - | Universitaire Ziekenhuizen KU Leuven | ||
| Sonazoid Enhanced Liver Cancer Trial for Early Detection | NCT00822991 | Hepatocellular ... Liver Cirrhosis Hepatitis B Hepatitis C | CE-US (Sonazoid... B-mode US | 20 Years - | Kindai University | |
| Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients | NCT00881036 | Hepatitis B | 18 Years - | Kyoto University Hospital | ||
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | NCT02108444 | Hepatitis Hepatitis B Lymphoma Hematologic Dis... | 18 Years - 80 Years | Peking University | ||
| Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma | NCT00767936 | Liver Cancer Hepatitis B Hepatitis C Hepatobiliary C... Hepatobiliary C... | 18 Years - | Stanford University | ||
| Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma | NCT00767936 | Liver Cancer Hepatitis B Hepatitis C Hepatobiliary C... Hepatobiliary C... | 18 Years - | Stanford University | ||
| Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells | NCT04032392 | Hepatocellular ... | autologous γδT ... | 18 Years - 70 Years | Beijing 302 Hospital | |
| Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma | NCT00155103 | Hepatitis B Carcinoma, Hepa... Polymorphism, G... | 18 Years - | National Taiwan University Hospital | ||
| Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy | NCT01768195 | Hepatitis B | Entecavir proph... | 18 Years - | Peking University | |
| Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone | NCT04710641 | Hepatocellular ... Hepatitis B Hepatitis C | MTL-CEBPA Sorafenib | 18 Years - | Mina Alpha Limited | |
| Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population | NCT03702998 | HIV Infections Hepatitis B Hepatitis C Hepatocellular ... | - | Chinese University of Hong Kong | ||
| Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans | NCT02760537 | Liver Neoplasms Hepatitis B | Lay Health Work... Placebo (a list... | 18 Years - | Thomas Jefferson University | |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) | NCT03680183 | Non Small Cell ... Hepatitis B | Entecavir 1Mg O... | 18 Years - 70 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients | NCT00881036 | Hepatitis B | 18 Years - | Kyoto University Hospital | ||
| National Liver Cancer Screening Trial | NCT06084234 | Carcinoma, Hepa... Liver Cancer Liver Cirrhosis Hepatitis B | GALAD Liver Ultrasoun... | 18 Years - 85 Years | University of Texas Southwestern Medical Center | |
| Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population | NCT03702998 | HIV Infections Hepatitis B Hepatitis C Hepatocellular ... | - | Chinese University of Hong Kong | ||
| Community-based Hepatitis B Interventions for Hmong Adults | NCT00888407 | Liver Cancer | HBV Screening -... Nutrition - Sma... | 18 Years - 64 Years | University of California, Davis | |
| Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy | NCT01768195 | Hepatitis B | Entecavir proph... | 18 Years - | Peking University | |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | NCT02108444 | Hepatitis Hepatitis B Lymphoma Hematologic Dis... | 18 Years - 80 Years | Peking University | ||
| Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan | NCT02402699 | Advanced Melano... Hepatitis B Hepatitis C | 18 Years - | Bristol-Myers Squibb | ||
| "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma | NCT04317248 | Hepatocellular ... | Cyclophosphamid... Multiple Signal... | 18 Years - 70 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191 | NCT01086709 | Cervical Neopla... HPV Infections | 21 Years - 30 Years | National Institutes of Health Clinical Center (CC) | ||
| Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma | NCT02025842 | Hepatocellular ... Hepatitis B | 18 Years - 75 Years | Azienda Ospedaliera San Camillo Forlanini | ||
| Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection | NCT01350648 | Hepatitis B Hepatitis C HIV-HCV Co-Infe... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy | NCT01970254 | Cancer Hepatitis B HBV Hepatitis B Inf... Malignant Neopl... | Hepatitis B Scr... Survey Administ... | 18 Years - | M.D. Anderson Cancer Center | |
| Increasing Hepatitis B Screening Among Korean Church Attendees | NCT00760721 | Hepatitis B | Educational Sma... | 18 Years - 64 Years | University of California, Los Angeles | |
| A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers | NCT00516945 | Hepatitis B Neoplasms | Lamivudine | 18 Years - 75 Years | Hospital Authority, Hong Kong | |
| The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study | NCT01831037 | Chronic Hepatit... Chronic Hepatit... | Regression of f... Specific risk f... | 18 Years - 70 Years | University of Arkansas | |
| Genes Involved in Resistance or Susceptibility to Hepatitis B Virus | NCT00342186 | Hepatitis, Vira... | 8 Years - 90 Years | National Institutes of Health Clinical Center (CC) | ||
| Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma | NCT02025842 | Hepatocellular ... Hepatitis B | 18 Years - 75 Years | Azienda Ospedaliera San Camillo Forlanini | ||
| Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B | NCT00926757 | Non Hodgkin's L... Hepatitis B | Entecavir proph... Therapeutic ent... | 16 Years - | Taipei Veterans General Hospital, Taiwan | |
| Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma | NCT02779465 | Hepatitis B Carcinoma, Hepa... | Vitamin D3 | 18 Years - 70 Years | Third Affiliated Hospital, Sun Yat-Sen University | |
| Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans | NCT02760537 | Liver Neoplasms Hepatitis B | Lay Health Work... Placebo (a list... | 18 Years - | Thomas Jefferson University | |
| Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine | NCT01580202 | Malignancy Hepatitis B | Entecavir Lamivudine | 18 Years - | Seoul National University Hospital | |
| Genetic Analysis of Liver Cancer | NCT00768001 | Liver Cancer Hepatitis B Hepatitis C Hepatobiliary C... Hepatobiliary C... | 18 Years - | Stanford University | ||
| Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma | NCT01765231 | Hepatitis B | Entecavir proph... Observation arm | 18 Years - | Peking University | |
| Application of HBV Rapid Tests as a Tool for Wide-Use Screening | NCT01767597 | Hepatitis B Liver Cirrhosis Carcinoma, Hepa... | ELISA testing Rapid testing | 18 Years - | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | |
| "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma | NCT04317248 | Hepatocellular ... | Cyclophosphamid... Multiple Signal... | 18 Years - 70 Years | Third Affiliated Hospital, Sun Yat-Sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
